| The Pharmaceutical Journal |
|
News summary |
| Related websites |
AstraZeneca invests £39m in UKAstraZeneca is investing over £39m in a new compound management and high throughput screening facility at its Alderley Park site in Cheshire. The project is part of a broader worldwide investment by the company, totalling almost £65m. |
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site
Map | Contact us
©The Pharmaceutical Journal